IL1B and rheumatoid arthritis: Moreover, the treatment of R-DHLA-AuNCs-Ce in IL-1β-induced HFLS and MC3T3-E1 cells might also indicate protective therapeutics of RA to present anti-inflammatory and osteogenic differentiation, contributing to RA recovery (Fig. 3 and Supplementary Figure 4-10).